Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma - Kudo, M; Ueshima, K; Ikeda, M (Liver Cancer, 2022)
et al.